Resona Asset Management’s Elevance Health ELV Stock Holding History

Resona Asset Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.4M	Sell	73,329 -7,619	-9%	-$2.83M	0.13%	134
2026 Q1	$23.6M	Sell	80,948 -4,489	-5%	-$1.48M	0.12%	167
2025 Q4	$29.9M	Sell	85,437 -3,266	-4%	-$1.1M	0.14%	125
2025 Q3	$28.6M	Sell	88,703 -3,514	-4%	-$1.09M	0.14%	141
2025 Q2	$35.8M	Buy	92,217 +10,069	+12%	+$4.05M	0.18%	114
2025 Q1	$35.7M	Buy	82,148 +5,862	+8%	+$2.35M	0.21%	102
2024 Q4	$28.2M	Sell	76,286 -3,995	-5%	-$1.67M	0.17%	114
2024 Q3	$41.8M	Sell	80,281 -1,253	-2%	-$669K	0.24%	83
2024 Q2	$44.1M	Buy	81,534 +465	+0.6%	+$246K	0.27%	71
2024 Q1	$42M	Buy	+81,069	New	+$40.3M	0.25%	84

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Resona Asset Management's ELV Position: Q2 2026 in Review

Resona Asset Management reduced its Elevance Health (ELV) stake by 9.4% in Q2 2026, selling an estimated $2.83M and leaving 73,329 shares worth $28.4M. The position accounts for 0.13% of the portfolio, ranked #134.

Resona Asset Management first reported a position in ELV in Q1 2024 and has held it in 10 quarters since. The position peaked at $44.1M in Q2 2024. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Resona Asset Management held 73,329 shares of Elevance Health worth $28.4M as of Q2 2026.
Resona Asset Management sold 7,619 Elevance Health shares in Q2 2026, an estimated $2.83M.
Elevance Health made up 0.13% of Resona Asset Management's portfolio in Q2 2026, its #134 holding.
Resona Asset Management first reported a position in Elevance Health in Q1 2024 and has held it in 10 quarters since.
Resona Asset Management's Elevance Health position peaked at $44.1M in Q2 2024.
1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Resona Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.